Should we focus on sustainable thromboprophylaxis and avoid overuse of low-molecular-weight heparins?
Low-molecular-weight heparins (LMWHs) have become a near-routine prescription for venous thromboembolism (VTE) prevention in hospitalized patients in several parts of the world. Their use may be reinforced by embedded order sets and ‘opt-out’ defaults. However, the absolute clinical benefit of unive...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2026-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2475037926034527 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|